文献速递胸部外周血管CT

深度学习重建联合对比增强提升在双低剂量CT肺动脉造影中的应用:一项两中心前瞻性试验

Deep learning reconstruction combined with contrast-enhancement boost in dual-low dose CT pulmonary angiography: a two-center prospective trial.
PubMed 文献 · Eur Radiol · 2025-05-24

这项两中心前瞻性研究纳入130例疑似肺栓塞患者,随机分为常规CTPA组(混合迭代重建)和双低剂量CTPA组(混合迭代重建、深度学习重建及对比增强提升生成HIR-boost与DLR-boost图像)。DLR-boost图像定性评分显著优于常规组HIR图像(p<0.001),肺动脉SNR和CNR为五组数据中最高(p<0.001),CT值相当(p>0.05);DLR、HIR-boost和DLR-boost诊断肺栓塞的AUC分别为0.933、0.924和0.986(均p>0.05)。结论认为DLR联合CE-boost技术可在降低辐射和对比剂剂量的同时显著改善CTPA图像质量,有助于更准确诊断肺栓塞。

要点

  • 双低剂量CTPA采用DLR联合CE-boost生成DLR-boost图像,定性评分显著优于常规CTPA的HIR图像(p<0.001)。
  • DLR-boost图像肺动脉SNR和CNR在五组数据中最高(p<0.001),CT值与常规HIR图像相当(p>0.05)。
  • DLR、HIR-boost和DLR-boost诊断肺栓塞的AUC分别为0.933、0.924和0.986,组间差异均p>0.05。

核心结论

  • DLR联合CE-boost技术可在降低辐射和对比剂剂量的条件下显著改善CTPA图像质量,有助于更准确地诊断肺栓塞。

研究设计与样本

  • 前瞻性两中心研究,纳入130例因疑似肺栓塞行CTPA的患者,随机分为常规CTPA组(HIR重建)和双低剂量CTPA组(HIR及DLR重建,并联合CE-boost生成HIR-boost和DLR-boost图像)。

关键影像表现/征象

  • 与常规组HIR图像相比,双低剂量组DLR-boost图像定性评分显著更优(p<0.001)。
  • DLR-boost图像与HIR图像的肺动脉CT值相当(p>0.05)。
  • DLR-boost图像肺动脉SNR和CNR为全部五组数据中最高(p<0.001)。

诊断标准与关键数值

  • 两名经验丰富的放射科医师根据整体图像噪声和血管对比度独立对CT图像排序(5分为最佳,1分为最差)。
  • DLR、HIR-boost和DLR-boost诊断肺栓塞的AUC分别为0.933、0.924和0.986(均p>0.05)。

临床应用与阅片要点

  • 双低剂量CTPA采用DLR联合CE-boost生成DLR-boost图像,可在降低辐射和对比剂剂量的同时获得优于常规HIR图像的定性评分。
  • DLR-boost图像肺动脉SNR和CNR为五组中最高,且CT值与常规HIR图像相当,阅片时可关注其图像噪声与血管对比表现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate whether the deep learning reconstruction (DLR) combined with contrast-enhancement-boost (CE-boost) technique can improve the diagnostic quality of CT pulmonary angiography (CTPA) at low radiation and contrast doses, compared with routine CTPA using hybrid iterative reconstruction (HIR).

MATERIALS AND METHODS: This prospective two-center study included 130 patients who underwent CTPA for suspected pulmonary embolism. Patients were randomly divided into two groups: the routine CTPA group, reconstructed using HIR; and the dual-low dose CTPA group, reconstructed using HIR and DLR, additionally combined with the CE-boost to generate HIR-boost and DLR-boost images. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of pulmonary arteries were quantitatively assessed. Two experienced radiologists independently ordered CT images (5, best; 1, worst) based on overall image noise and vascular contrast. Diagnostic performance for PE detection was calculated for each dataset.

RESULTS: Patient demographics were similar between groups. Compared to HIR images of the routine group, DLR-boost images of the dual-low dose group were significantly better at qualitative scores (p < 0.001). The CT values of pulmonary arteries between the DLR-boost and the HIR images were comparable (p > 0.05), whereas the SNRs and CNRs of pulmonary arteries in the DLR-boost images were the highest among all five datasets (p < 0.001). The AUCs of DLR, HIR-boost, and DLR-boost were 0.933, 0.924, and 0.986, respectively (all p > 0.05).

CONCLUSION: DLR combined with CE-boost technique can significantly improve the image quality of CTPA with reduced radiation and contrast doses, facilitating a more accurate diagnosis of pulmonary embolism.

KEY POINTS: Question The dual-low dose protocol is essential for detecting pulmonary emboli (PE) in follow-up CT pulmonary angiography (PA), yet effective solutions are still lacking. Findings Deep learning reconstruction (DLR)-boost with reduced radiation and contrast doses demonstrated higher quantitative and qualitative image quality than hybrid-iterative reconstruction in the routine CTPA. Clinical relevance DLR-boost based low-radiation and low-contrast-dose CTPA protocol offers a novel strategy to further enhance the image quality and diagnosis accuracy for pulmonary embolism patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Shen L, Lu J, Zhou C, et al. Deep learning reconstruction combined with contrast-enhancement boost in dual-low dose CT pulmonary angiography: a two-center prospective trial. Eur Radiol. 2025. PMID: 40411550. doi:10.1007/s00330-025-11681-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。